SHELTON, CT / / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") today announced that it has engaged a Clinical Research Organization (CRO) to ...

Toleranzia AB (the "Company" or "Toleranzia") announces that the process for the Company's clinical trial application is proceeding in accordance with the medicinal agencies' usual course. On January ...

Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

The confirmatory IGNYTE-3 trial is assessing RP1 in combination with nivolumab in patients with advanced melanoma who have progressed on anti-PD-1 and anti-CTLA-4 therapies or are ineligible for ...

FDA denies Vanda's Tradipitant application for gastroparesis, urging new trials for efficacy and safety. Vanda disputes the agency's review process.

The "Delhi Election 2025 QMS (queue management system)" mobile application is set for final trial on January 15 and 16. The digital queue monitoring system was available for voters in Haryana, Punjab ...

The Australian Government’s Department of Health and Aged Care has announced the ‘2024 Clinical Trial Enabling Infrastructure ... sector through new or expanded trial practice networks. Applications ...

The National Testing Agency (NTA) has commenced registrations for the Common University Entrance Test for Postgraduate (CUET PG) 2025, with applications open until February 1, 2025. Conducted ...

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has announced a streamlined procedure for submitting applications related to ...